Compare GSK Pharma with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs GLENMARK LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA GLENMARK LIFE SCIENCES GSK PHARMA/
GLENMARK LIFE SCIENCES
 
P/E (TTM) x 56.4 - - View Chart
P/BV x 18.7 9.3 201.1% View Chart
Dividend Yield % 1.8 0.0 -  

Financials

 GSK PHARMA   GLENMARK LIFE SCIENCES
EQUITY SHARE DATA
    GSK PHARMA
Mar-21
GLENMARK LIFE SCIENCES
Mar-21
GSK PHARMA/
GLENMARK LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,805NA-   
Low Rs1,155NA-   
Sales per share (Unadj.) Rs188.81,923.6 9.8%  
Earnings per share (Unadj.) Rs21.1358.8 5.9%  
Cash flow per share (Unadj.) Rs25.8392.8 6.6%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %2.0NM- 
Book value per share (Unadj.) Rs88.5768.1 11.5%  
Shares outstanding (eoy) m169.419.80 1,728.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.80-   
Avg P/E ratio x70.00-  
P/CF ratio (eoy) x57.30-  
Price / Book Value ratio x16.70-  
Dividend payout %141.90-   
Avg Mkt Cap Rs m250,6950-   
No. of employees `000NANA-   
Total wages/salary Rs m6,1471,491 412.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,98918,852 169.7%  
Other income Rs m1,1068 13,635.4%   
Total revenues Rs m33,09418,860 175.5%   
Gross profit Rs m5,2275,911 88.4%  
Depreciation Rs m793334 237.4%   
Interest Rs m35875 4.0%   
Profit before tax Rs m5,5054,709 116.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9241,194 161.1%   
Profit after tax Rs m3,5813,516 101.9%  
Gross profit margin %16.331.4 52.1%  
Effective tax rate %34.925.3 137.9%   
Net profit margin %11.218.6 60.0%  
BALANCE SHEET DATA
Current assets Rs m22,02713,990 157.4%   
Current liabilities Rs m13,32512,214 109.1%   
Net working cap to sales %27.29.4 288.7%  
Current ratio x1.71.1 144.3%  
Inventory Days Days472 2,170.0%  
Debtors Days Days246120 205.1%  
Net fixed assets Rs m8,0765,980 135.0%   
Share capital Rs m1,69420 8,643.2%   
"Free" reserves Rs m13,2977,508 177.1%   
Net worth Rs m14,9917,527 199.1%   
Long term debt Rs m00-   
Total assets Rs m30,10219,971 150.7%  
Interest coverage x156.96.4 2,459.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.10.9 112.6%   
Return on assets %12.022.0 54.6%  
Return on equity %23.946.7 51.2%  
Return on capital %37.074.2 49.8%  
Exports to sales %00-   
Imports to sales %0.90-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m276NA-   
Fx inflow Rs m2787,870 3.5%   
Fx outflow Rs m2763,955 7.0%   
Net fx Rs m23,915 0.1%   
CASH FLOW
From Operations Rs m5,77912,434 46.5%  
From Investments Rs m4,186-12,352 -33.9%  
From Financial Activity Rs m-6,961-808 861.6%  
Net Cashflow Rs m3,004-726 -413.9%  

Share Holding

Indian Promoters % 0.0 82.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 12.8 8.8 145.3%  
FIIs % 2.0 8.3 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 17.2 145.7%  
Shareholders   123,480 253,726 48.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

GSK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GSK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Jan 25, 2022 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS